Physician profile
Dixitha Anugula
NPI 1104201722
$1,224.06
in general payments reported to CMS, 2019-2025
16 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.20 · 2021: $315 · 2022: $258 · 2023: $465 · 2024: $14.89 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $314.50 | 2021 | |
| Medtronic, INC. | $219.83 | 2022-2024 | Cobalt Dr Mri Surescan, Percepta Quad Crt-P Mri Surescan, Azure Xt Dr Mri Surescan |
| Kiniksa Pharmaceuticals, LTD. | $142.90 | 2022-2023 | Arcalyst |
| Astellas Pharma US INC | $99.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $89.27 | 2022-2023 | |
| Amgen INC. | $87.25 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $72.52 | 2023-2025 | |
| Abiomed | $38.07 | 2025 | |
| Lantheus Medical Imaging, INC. | $26.10 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.51 | 2023 | Jardiance |
| W. L. Gore & Associates, INC. | $23.20 | 2020 | |
| Cathworks, INC. | $22.94 | 2025 | Ffrangio |
| Bayer Healthcare Pharmaceuticals INC. | $20.32 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $15.87 | 2025 | Eliquis |
| Surmodics, INC. | $15.86 | 2023 | Sublime Radial Access Guide Sheath, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dixitha Anugula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.